Hormone therapy dose, formulation, route of delivery, and risk of cardiovascular events in women: Findings from the Women's Health Initiative Observational Study

Authors

Chrisandra L. Shufelt, Cedars-Sinai Heart Institute, Los Angeles, CA
C. Noel Bairey Merz, Cedars-Sinai Heart Institute, Los Angeles, CA
Ross L. Prentice, Fred Hutchinson Cancer Research Center, Seattle, WA
Mary B. Pettinger, Fred Hutchinson Cancer Research Center, Seattle, WA
Jacques E. Rossouw, National Institutes of Health, Bethesda, MD
Vanita R. Aroda, MedStar Health Research Institute, Hyattsville, MD
Andrew M. Kaunitz, University of Florida
Kamakshi Lakshminarayan, University of Minnesota
Lisa W. Martin, George Washington UniversityFollow
Lawrence S. Phillips, Emory University
Joann E. Manson, Harvard Medical School

Document Type

Journal Article

Publication Date

3-2014

Journal

Menopause

Volume

Volume 21, Issue 3

Inclusive Pages

260-266

APA Citation

Shufelt, C.L., Merz, C.N.B., Prentice, R.L., Pettinger, M.B., Rossouw, J.E. et al. (2014). Hormone therapy dose, formulation, route of delivery, and risk of cardiovascular events in women: Findings from the Women's Health Initiative Observational Study. Menopause, 21(3), 260-266.

Peer Reviewed

1